Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serial Magnetic Resonance Imaging of Longitudinal Radiotherapy-Attributable Normal Tissue Injury

NCT04265430 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT04265430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04265430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serial Magnetic Resonance Imaging of Longitudinal Radiotherapy-Attributable Normal Tissue Injury
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 4
Overall status
Recruiting
Start date
September 17, 2018
Completion date
September 1, 2031
Enrollment
425 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant oral cavity neoplasm, malignant skull base neoplasm, osteoradionecrosis